Eric Gordon MD

Eric Gordon is the founder of Gordon Medical Associates, an internationally recognized treatment center for difficult to diagnosis and treat conditions, including Lyme, Chronic Fatigue Syndrome, Fibromyalgia, Autism, Multiple Chemical Sensitivity, and other illness that is often overlooked or left untreated.

video

Eric Gordon, MD on Using the Molekule Air Purifier in Our Office

Patients at GMA are uniquely sensitive to many things, and odors, scents, and air pollution are often one of the biggest issues they deal with. Though we have searched for air purifiers that helped our patients, we never had one that we were truly satisfied with. Until now.

We first heard about Molekule Air Purification from our patients. It almost sounded too good to be true. We found the PECO units do not filter, absorb, or block toxins in the air. The PECO technology literally takes the toxins apart, down to the molecular level. PECO is an innovative technology that utilizes free radicals—the same radicals used to kill cancer cells—to oxidize pollutants. By using nanotechnology, PECO is able to destroy pollutants 1000 times smaller than traditional HEPA filters (0.1 nanometers versus 300 nanometers). Toxins are broken down into carbon dioxide, water, and trace elements.

Our most sensitive staff, along with several who participated in Molekule’s beta study, all had notable positive results.

Find out more about Molekule.

Learn about the special on Molekule for GMA patients and friends.

video

U.K. patients describe Myalgic Encephalomyelitis (ME) or (ME/CFS)

*Often called chronic fatigue syndrome (CFS) or ME/CFS


Video by M.E. Action

Patients like these are why Dr. Gordon began research into chronic illness. Find out about our Science in Service of Humanity metabolomics research in CFS/ME. Read our published study, “Metabolic Features of Chronic Fatigue Syndrome,” watch for the next study to be published in the fall of 2017, sign up to participate in new research as a patient or a healthy control, and donate to support the work.

Evidence that CFS truly does deserve all three elements of its name has accumulated over the years but a definitive diagnostic test has remained elusive. Until, perhaps, now. For in this week’s Proceedings of the National Academy of Sciences Robert Naviaux of the University of California, San Diego, and his colleagues published evidence that the metabolisms of those diagnosed with CFS are all changing in the same way. Their data suggest it is this cellular response to CFS-triggering traumas, and not the way the response is set in motion, which should define the illness. They also show that this response produces a chemical signal that might be used for diagnosis.

The Economist

post

Update on SISOH Metabolomics Research 4/6/17

Eric Gordon MD and Wayne Anderson ND at SISOH

Eric Gordon MD and Wayne Anderson ND – photo courtesy of the Press Democrat, Christopher Chung

From Eric Gordon, MD

Many of you are probably wondering where we are with the SISOH research. Good news is that Kelly Fox, previously one of the Medical Assistants at GMA, has come on as a full-time Research Coordinator! Kelly is very experienced in working with chronically ill patients, and we think you will find her a delight to work with.

Our ongoing CFS/ME studies are group studies working to develop an accepted group of biomarkers to define people with CFS/ME. We have enrolled all the patients in the replication study with Dr. Cheney, and hope to publish that in fall of 2017. [Read more…]

video

Videos from the Millions Missing Rally

Eric Gordon at Millions Missing rally

Eric Gordon speaking at the Millions Missing ME/CFS rally on September 27

You can see videos of the speakers at the San Francisco Millions Missing rally on Facebook at the Chronic Fatigue Syndrome Research Center at Stanford University page.

Following patient speakers, you can hear Eric Gordon speak (video) beginning at about 31.35  minutes in.

Ron Davis follows talking about how to get more research happening.

Millions Missing San Francisco video on Facebook

More speakers (video)

gallery

Images from the Millions Missing Rally for ME/CFS

post

Press Democrat: Santa Rosa doctor’s study offers new insight into chronic fatigue syndrome

GUY KOVNER
THE PRESS DEMOCRAT | September 21, 2016

Eric Gordon MDA new study initiated by (Eric) Gordon and including Harrison as one of the subjects could provide that breakthrough.

The study, published last month, detected a “chemical signature” in the blood of chronic fatigue syndrome patients, establishing for the first time that chronic fatigue syndrome is an “objective metabolic disorder,” said co-author Dr. Robert Naviaux, the UC San Diego researcher who identified the blood chemical anomalies associated with the condition.

Gordon is a co-author of the study, and most of the patients in the study came from his practice.

Read PD Article

Read Full Study Paper

post

New Study Published: Metabolic features of chronic fatigue syndrome

Robert NaviauxMetabolic features of chronic fatigue syndrome. Naviaux RK, Naviaux JC, Li K, Bright AT, Alaynick WA, Wang L, Baxter A, Nathan N, Anderson W, Gordon E. Proc Natl Acad Sci U S A. 2016 Aug 29.

Download a PDF copy – Metabolic features of chronic fatigue syndrome

The Metabolomics study done in collaboration with Robert Naviaux of the Naviaux Lab and Gordon Medical Associates is now available!

Here we report a metabolomics study of Chronic Fatigue Syndrome (CFS) in 45 CFS patients and 39 controls. Our data show that despite the heterogeneity of factors leading to CFS, the cellular metabolic response in patients was homogeneous, statistically robust, and chemically similar to the evolutionarily conserved persistence response to environmental stress known as dauer.

Read full paper…

Some people still argue that CFS is not a real illness but all in the mind. Does your discovery of a chemical signature help shatter this myth?

Yes. The chemical signature that we discovered is evidence that CFS is an objective metabolic disorder that affects mitochondrial energy metabolism, immune function, GI function, the microbiome, the autonomic nervous system, neuroendocrine, and other brain functions. These 7 systems are all connected in a network that is in constant communication. While it is true that you cannot change one of these 7 systems without producing compensatory changes in the others, it is the language of chemistry and metabolism that interconnects them all.

Metabolomics Q&A for CFS v6 

Support further research at the Gordon Medical Research Center

status

Gordon Medical Research Center Now Funding Replication Study on CFIDS/ME Findings

Eric Gordon MDBy Eric Gordon, MD

The collaboration of an innovative medical practice with a university research center has been my lifelong dream.  Combining forces with Dr. Robert Naviaux and his research into metabolomics, mitochondrial function, and chronic inflammatory disease is now bringing this dream to life.

The opening of the Gordon Medical Research Center is a critical element in developing funding for the research into the complex illnesses we focus on. Your donation will make possible further research into metabolomics and mitochondrial function and their impact on health and illness. Illnesses potentially caused by mitochondrial dysfunction will ultimately affect over 50% of the people born today. These diseases include autoimmune diseases, autism, Myalgic Encephalopathy/Chronic Fatigue Syndrome  (ME/CFS), Post-Traumatic Stress Disorder (PTSD), Gulf War Illness,  diabetes, heart disease, certain mental health disorders, and cancer.

Eric Gordon, MD
Founder, Gordon Medical Associates
Science in Service of Humanity
Gordon Medical Research Center
Funding Research For Poorly Defined and Undiagnosed Chronic Illness

Dr. Robert Naviaux and I have submitted for publication a study, now under peer review and expected to be published in the fall of 2016, [Read more…]

status

Patient Powered Research into Lyme Disease

We recommend that you look into the research being done by LymeDisease.org through MyLymeData. Being able to collect information from thousands of Lyme patients has the potential to open up new avenues of Lyme disease research. Watch the video, and then go to the website to learn more, and sign up to participate!

Imagine a world where people with Lyme disease are diagnosed and treated correctly and go back to living their lives.

YOU CAN BE PART OF MAKING THIS HAPPEN
Add your Lyme data to MyLymeData
to help find a cure for Lyme disease.

MyLymeData is a patient-powered research project. It was conceived by patients, is run by patients, and addresses the issues that patients care about. It lets Lyme disease patients learn from each other and provides data that can help drive research to improve their lives.

post

Did you ever think it would be possible to significantly decrease or even cure persistent pain without strong drugs or injections?

 

Neuroplastix

Change the Brain; Relieve the Pain; Transform the Person

Dr. Michael Moskowitz MD has developed a strategy called  “Neuroplastic Transformation” training the brain to change itself back to the healthy state that existed before persistent pain developed.  Neuroplastix is dedicated to curing the disease of persistent pain in all people who suffer by unifying brain and body as the focus of treatment.

The educational programs establish a new paradigm in pain care, bringing advances in neuroscience to anyone affected by persistent pain, including patients, their families and providers. This is accomplished via conferences, interactive materials, scientific publications and professional training, providing a method to transform the clinical treatment of pain.

For more information on Dr. Moskowitz go to www.neuroplastix.com

Join Dr. Moskowitz  in person and via webinar Wednesday May 11th 6:30 – 8:30 pm MDT and celebrate International Awareness Day for ME/CFS, FM and MCS.

To register go to:  www.selfconnection.ca/moskowitz